Showing results (1161-1170 of 1,193) with videos related to
Sort By:
Pageof 120
Plos Pathogens|June 23, 2023
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogensHuntly M Morrison, Julia Craft, Rafael Rivera-Lugo, et al.Nature|July 17, 2007
A genome-wide association study identifies KIAA0350 as a type 1 diabetes geneHakon Hakonarson, Struan F A Grant, Jonathan P Bradfield, et al.ACS Infectious Diseases|June 15, 2021
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2Scott B Biering, Erik Van Dis, Eddie Wehri, et al.Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.Journal of Proteome Research|September 6, 2013
Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometersKelly A Jones, Phillip D Kim, Bhavinkumar B Patel, et al.The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.Translational Psychiatry|August 8, 2023
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorderJonathan D Santoro, Noemi A Spinazzi, Robyn A Filipink, et al.Diabetes|January 17, 2008
A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association studyHakon Hakonarson, Hui-Qi Qu, Jonathan P Bradfield, et al.Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.Gut Pathogens|February 5, 2025
Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in UgandaCarolina Agudelo, David Patrick Kateete, Emmanuel Nasinghe, et al.Pageof 120